Somewhat Positive Media Coverage Somewhat Unlikely to Impact Barclays (NYSE:BCS) Stock Price

Share on StockTwits

Headlines about Barclays (NYSE:BCS) have been trending somewhat positive this week, Accern Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Barclays earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave media coverage about the financial services provider an impact score of 44.7026599361491 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

These are some of the media stories that may have effected Accern Sentiment’s scoring:

Shares of NYSE:BCS opened at $12.02 on Friday. The firm has a market cap of $50,892.68, a PE ratio of 14.48, a price-to-earnings-growth ratio of 0.59 and a beta of 0.81. The company has a debt-to-equity ratio of 4.10, a quick ratio of 1.27 and a current ratio of 1.27. Barclays has a 1 year low of $9.29 and a 1 year high of $12.47.

The firm also recently declared a special dividend, which was paid on Thursday, April 5th. Stockholders of record on Friday, March 2nd were issued a dividend of $0.1115 per share. The ex-dividend date was Thursday, March 1st. Barclays’s payout ratio is currently 26.51%.

A number of analysts have recently issued reports on the company. ValuEngine downgraded Barclays from a “buy” rating to a “hold” rating in a research report on Monday. Investec cut Barclays from a “buy” rating to a “hold” rating in a report on Tuesday, March 20th. BCS raised Barclays to a “sell” rating in a report on Thursday, March 8th. Zacks Investment Research raised Barclays from a “sell” rating to a “hold” rating in a research note on Monday, January 22nd. Finally, JPMorgan Chase reissued a “buy” rating on shares of Barclays in a research note on Monday, March 19th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $11.00.

In related news, major shareholder Plc Barclays sold 25,000 shares of the company’s stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $10.00, for a total transaction of $250,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last quarter, insiders have sold 29,627 shares of company stock valued at $300,992. 0.02% of the stock is owned by company insiders.

TRADEMARK VIOLATION WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Barclays (NYSE:BCS) Stock Price” was originally reported by BBNS and is the property of of BBNS. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at https://baseballnewssource.com/2018/04/06/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-barclays-bcs-share-price/2031104.html.

Barclays Company Profile

Barclays PLC, through its subsidiaries, provides various financial products and services in the United Kingdom, other European countries, the Americas, Africa, the Middle East, and Asia. The company operates through Barclays UK and Barclays International divisions. It offers personal and business banking services; credit and debit cards; international banking; and private banking services, which include investment, wealth planning, and credit and specialist solutions to high net worth and ultra-high net worth clients, and family offices.

Insider Buying and Selling by Quarter for Barclays (NYSE:BCS)

Receive News & Ratings for Barclays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Barclays and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.